Advertisement

Topics

Fusion Antibodies on recovery tack after float disruption

06:00 EST 6 Dec 2018 | Proactive Investors

The reason for the IPO was to provide funds to expand and Fusion has kept to its plans.

Original Article: Fusion Antibodies on recovery tack after float disruption

NEXT ARTICLE

More From BioPortfolio on "Fusion Antibodies on recovery tack after float disruption"

Advertisement
Quick Search
Advertisement
Advertisement